Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Emerging Therapies
Emerging Therapies
Lixisenatide Continues to Show Good Results in GetGoal Program Studies
Mary Mosley
Play Video
Emerging Therapies
Lixisenatide Continues to Show Good Results in GetGoal Program Studies
Mary Mosley
Play Video
Emerging Therapies
LOXO-292 Highly Effective in RET-Positive Cancers
Chase Doyle
Play Video
Emerging Therapies
Magrolimab, First CD47 Antibody, Shows Promise in Combination with Azacitidine in Unfit Patients with Acute Myeloid Leukemia
Wayne Kuznar
Wayne Kuznar
Play Video
Emerging Therapies
Midostaurin the First Targeted Therapy to Improve Survival in AML: Potentially Practice-Changing
Phoebe Starr
Play Video
Emerging Therapies
Mosunetuzumab, a Dual-Targeted Antibody, Shows Complete Remissions in Relapsed/Refractory NHL After CAR T-Cell Therapy
Phoebe Starr
Phoebe Starr
Play Video
Emerging Therapies
New Long-Acting Insulin Degludec Lowers Hypoglycemia Significantly versus Insulin Glargine
Wayne Kuznar
Play Video
Emerging Therapies
New Long-Acting Insulin Degludec Lowers Hypoglycemia Significantly versus Insulin Glargine
Wayne Kuznar
Play Video
Emerging Therapies
New Standard in Elderly Patients with Glioblastoma Based on Phase 3 Evidence
Phoebe Starr
Play Video
Emerging Therapies
Nivolumab Beats Docetaxel as Second-Line Therapy for Patients with NSCLC
Phoebe Starr
Play Video
1
2
3
4
5
6
7
Page 4 of 7
Results 31 - 40 of 67